Jingga Morry

发表

Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted siRNA Delivery to HER2+ Breast Cancer

Samuel A. Mihelic, J. Gray, Shenda Gu, 2015, Advanced functional materials.

Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform

J. Gray, Shenda Gu, W. Yantasee, 2017, Molecular Cancer Therapeutics.

Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles

W. Yantasee, Worapol Ngamcherdtrakul, J. Morry, 2016, Redox biology.

Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment.

J. Gray, Shenda Gu, W. Yantasee, 2016, Cancer treatment reviews.

Novel Oral Detoxification of Mercury, Cadmium, And Lead with Thiol-Modified Nanoporous Silica

G. Fryxell, R. Addleman, David Castro, 2014, ACS applied materials & interfaces.

Dermal delivery of HSP47 siRNA with NOX4-modulating mesoporous silica-based nanoparticles for treating fibrosis.

Shenda Gu, W. Yantasee, Thanapon Sangvanich, 2015, Biomaterials.

Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens.

L. Stanberry, J. Baker, L. Stanberry, 2012, Vaccine.

Nanoporous sorbent material as an oral phosphate binder and for aqueous phosphate, chromate, and arsenate removal.

G. Fryxell, W. Yantasee, Thanapon Sangvanich, 2014, Journal of nanomedicine & nanotechnology.

Therapeutic siRNA for drug-resistant HER2-positive breast cancer

J. Gray, Shenda Gu, W. Yantasee, 2016, Oncotarget.

Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis.

Thommey P. Thomas, A. Koch, I. Bergin, 2015, Journal of biomedical nanotechnology.